Utah Medical Products, Inc.
UTMD
Market Cap$172.82M
Close$
$113.30
110.3% upside
Current Fair Value
110.3% upsideUndervalued by 110.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $172.82 Million |
|---|---|
| Enterprise Value | $90.46 Million |
| Dividend Yield | $1.21 (2.29775921002659%) |
| Earnings per Share | $3.96 |
| Beta | 0.18 |
| Outstanding Shares | 3,310,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 13.45 |
|---|---|
| PEG | -142.66 |
| Price to Sales | 4.14 |
| Price to Book Ratio | 1.54 |
| Enterprise Value to Revenue | 2.05 |
| Enterprise Value to EBIT | 5.86 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Utah Medical Products, Inc.
CEO: Kevin Cornwell Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hund...